The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Wilhelm, S. M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1443 · Cited by 4,017
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M., Rzhetsky, A., & Allikmets, R. (2001) · Genome Research · doi:10.1101/gr.184901 · Cited by 1,748
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL
Kantarjian, H., Giles, F., Wunderle, L., Bhalla, K., O'Brien, S., Wassmann, B., Tanaka, C., Manley, P., Rae, P., Mietlowski, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055104 · Cited by 1,344
Expression of Multidrug Resistance Gene in Human Cancers
Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.116 · Cited by 1,290
A distinct “side population” of cells with high drug efflux capacity in human tumor cells
Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Nuchtern, J. G., Jax, T. W., Gobel, U., Goodell, M. A., & Brenner, M. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400067101 · Cited by 1,280
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
Wood, E. R., Truesdale, A. T., McDonald, O. B., Yuan, D., Hassell, A., Dickerson, S. H., Ellis, B., Pennisi, C., Horne, E., Lackey, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1168 · Cited by 1,122
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M. (2001) · Genome Research · doi:10.1101/gr.gr-1649r · Cited by 1,113
Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment
Goldman, J. M., & Melo, J. V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020777 · Cited by 950
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Thomas, H., & Coley, H. M. (2003) · Cancer Control · doi:10.1177/107327480301000207 · Cited by 931
Sparreboom, A., van Asperen, J., Mayer, U., Schinkel, A. H., Smit, J. W., Meijer, D. K. F., Borst, P., Nooijen, W. J., Beijnen, J. H., & van Tellingen, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2031 · Cited by 882
BindingDB (2025) · PubMed · doi:10.7270/q2dr317m · Cited by 843
The Role of ABC Transporters in Clinical Practice
Leonard, G. D., Fojo, T., & Bates, S. E. (2003) · The Oncologist · doi:10.1634/theoncologist.8-5-411 · Cited by 817
Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., & Deeley, R. G. (1994) · PubMed · Cited by 770
Deeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761
Sarkadi, B., Homolya, L., Szakács, G., & Váradi, A. (2006) · Physiological Reviews · doi:10.1152/physrev.00037.2005 · Cited by 726
Mechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
EVOLUTION OF THE ATP-BINDING CASSETTE (ABC) TRANSPORTER SUPERFAMILY IN VERTEBRATES
Dean, M., & Annilo, T. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162122 · Cited by 650
The MRP family of drug efflux pumps
Kruh, G. D., & Belinsky, M. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206953 · Cited by 614
The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity
Glavinas, H., Krajcsi, P., Cserepes, J., & Sarkadi, B. (2004) · Current Drug Delivery · doi:10.2174/1567201043480036 · Cited by 558
Litman, T., Brangi, M., Hudson, E., Fetsch, P., Abati, A., Ross, D. D., Miyake, K., Resau, J. H., & Bates, S. E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.2011 · Cited by 538
Hyafil, F., Pauwels-Vergely, C., Vignaud, P. D., & Grand‐Perret, T. (1993) · PubMed · Cited by 525
Rabindran, S. K., Ross, D. D., Doyle, L. A., Yang, W., & Greenberger, L. M. (2000) · PubMed · Cited by 487
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.
Hooijberg, J. H., Broxterman, H. J., Kool, M., Assaraf, Y. G., Peters, G. J., Noordhuis, P., Scheper, R. J., Borst, P., Pinedo, H. M., & Jansen, G. (1999) · PubMed · Cited by 442
Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Pérez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M. C., & Bates, S. E. (2001) · PubMed · Cited by 429
ABC Transporters, Drug Resistance, and Cancer Stem Cells
Dean, M. (2009) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-009-9109-9 · Cited by 425
Choi, K., Chen, C.-J., Kriegler, M., & Roninson, I. B. (1988) · Cell · doi:10.1016/0092-8674(88)90568-5 · Cited by 423
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT
Dubreuil, P., Letard, S., Ciufolini, M., Gros, L., Humbert, M., Castéran, N., Borge, L., Hajem, B., Lermet, A., Sippl, W., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007258 · Cited by 421
Localisation of breast cancer resistance protein in microvessel endothelium of human brain
Cooray, H. C., Blackmore, C. G., Maskell, L., & Barrand, M. A. (2002) · NeuroReport · doi:10.1097/00001756-200211150-00014 · Cited by 419
List, A. F., Kopecky, K. J., Willman, C. L., Head, D. R., Persons, D. L., Slovak, M. L., Dorr, R., Karanes, C., Hynes, H. E., Doroshow, J. H., et al. (2001) · Blood · doi:10.1182/blood.v98.12.3212 · Cited by 419
The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein
Ueda, K., Cornwell, M. M., Gottesman, M. M., Pastan, I., Roninson, I. B., Ling, V., & Riordan, J. R. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80136-x · Cited by 411
Role of the breast cancer resistance protein (ABCG2) in drug transport
Mao, Q. (2005) · The AAPS Journal · doi:10.1208/aapsj070112 · Cited by 405
Arteaga, C. L. (2001) · PubMed · Cited by 397
Pharmacological Strategies for Overcoming Multidrug Resistance
Nobili, S., Landini, I., Giglioni, B., & Mini, E. (2006) · Current Drug Targets · doi:10.2174/138945006777709593 · Cited by 393
ABCG2: determining its relevance in clinical drug resistance
Robey, R. W., Polgar, O., Deeken, J., To, K. W., & Bates, S. E. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9042-6 · Cited by 387
Dai, C.-L., Tiwari, A. K., Wu, C.-P., Su, X.-D., Wang, S.-R., Liu, D.-G., Ashby, C. R., Huang, Y., Robey, R. W., Liang, Y.-J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0499 · Cited by 386
Self-citationMultidrug resistance transporters and modulation
Tan, B., Piwnica-Worms, D., & Ratner, L. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200009000-00011 · Cited by 384
Huang, W.-S., Metcalf, C. A., Sundaramoorthi, R., Wang, Y., Zou, D., Thomas, R. M., Zhu, X., Cai, L., Wen, D., Liu, S., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100395q · Cited by 369
Baer, M. R., George, S. L., Dodge, R. K., O'Loughlin, K. L., Minderman, H., Caligiuri, M. A., Anastasi, J., Powell, B. L., Kolitz, J. E., Schiffer, C. A., et al. (2002) · Blood · doi:10.1182/blood.v100.4.1224.h81602001224_1224_1232 · Cited by 366
Overview: ABC Transporters and Human Disease
Gottesman, M. M., & Ambudkar, S. V. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012866803188 · Cited by 350
(2001) · PubMed · Cited by 350
High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter
Özvegy-Laczka, C., Hegedűs, T., Várady, G., Ujhelly, O., Schuetz, J. D., Váradi, A., Kéri, G., Őrfi, L., Német, K., & Sarkadi, B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1485 · Cited by 340
Molecular basis of antifolate resistance
Assaraf, Y. G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9049-z · Cited by 338
Functional Multidrug Resistance Protein (MRP1) Lacking the N-terminal Transmembrane Domain
Bakos, É., Evers, R., Szakács, G., Tusnády, G. E., Welker, E., Szabó, K., de Haas, M., van Deemter, L., Borst, P., Váradi, A., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32167 · Cited by 326
Shi, Z., Peng, X.-X., Kim, I.-W., Shukla, S., Si, Q.-S., Robey, R. W., Bates, S. E., Shen, T., Ashby, C. R., Fu, L.-W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2686 · Cited by 315
Self-citationChen, Z., Robey, R. W., Belinsky, M. G., Shchaveleva, I., Ren, X. Q., Sugimoto, Y., Ross, D. D., Bates, S. E., & Kruh, G. D. (2003) · PubMed · Cited by 305
Self-citationMultidrug resistance associated proteins in multidrug resistance
Sodani, K., Patel, A., Kathawala, R. J., & Chen, Z.-S. (2012) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10329 · Cited by 300
Self-citationLum, B. L., Kaubisch, S., Yahanda, A. M., Adler, K. M., Jew, L., Ehsan, M. N., Brophy, N. A., Halsey, J., Gosland, M. P., & Sikic, B. I. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.10.1635 · Cited by 299
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
Sikic, B. I. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051055 · Cited by 277
Smaill, J. B., Rewcastle, G. W., Loo, J. A., Greis, K. D., Chan, O. H., Reyner, E. L., Lipka, E., Showalter, H. D. H., Vincent, P. W., Elliott, W. L., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990482t · Cited by 269
The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoprotein
Martin, C., Berridge, G., Mistry, P., Higgins, C., Charlton, P., & Callaghan, R. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702807 · Cited by 258
Development of inhibitors of ATP-binding cassette drug transporters – present status and challenges
Shukla, S., Wu, C.-P., & Ambudkar, S. V. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.2.205 · Cited by 253
Evolution of ATP-binding cassette transporter genes
Dean, M. (1995) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(95)80011-s · Cited by 245
Marsh, S., Paul, J., King, C. R., Gifford, G., McLeod, H. L., & Brown, R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4752 · Cited by 238
Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator
Qadir, M., O'Loughlin, K. L., Fricke, S. M., Williamson, N. A., Greco, W. R., Minderman, H., & Baer, M. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1725 · Cited by 236
The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
Wu, C.-P., Hsieh, C.-H., & Wu, Y.-S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200261n · Cited by 234
The structure of Escherichia coli BtuF and binding to its cognate ATP binding cassette transporter
Borths, E. L., Locher, K. P., Lee, A. T., & Rees, D. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262659699 · Cited by 225
Shukla, S., Robey, R. W., Bates, S. E., & Ambudkar, S. V. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024612 · Cited by 225
Erlichman, C., Boerner, S. A., Hallgren, C. G., Spieker, R. S., Wang, X., James, C. D., Scheffer, G. L., Maliepaard, M., Ross, D. D., Bible, K. C., et al. (2001) · PubMed · Cited by 224
Liu, J., Chen, H., Miller, D. S., Saavedra, J. E., Keefer, L. K., Johnson, D. R., Klaassen, C. D., & Waalkes, M. P. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23133-3 · Cited by 221
Higgins, C. F., Hiles, I. D., Whalley, K., & Jamieson, D. J. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03735.x · Cited by 218
Alvarez, M., Paull, K., Monks, A., Hose, C., Lee, J. S., Weinstein, J., Grever, M., Bates, S., & Fojo, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117910 · Cited by 216
Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.
Yahanda, A. M., Alder, K. M., Fisher, G. A., Brophy, N. A., Halsey, J., Hardy, R. I., Gosland, M. P., Lum, B. L., & Sikic, B. I. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.10.1624 · Cited by 214
Ecteinascidin 743: A Minor Groove Alkylator That Bends DNA toward the Major Groove
Zewail-Foote, M., & Hurley, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990241l · Cited by 214
Evidence that Resistance to Nilotinib May Be Due to BCR-ABL, Pgp, or Src Kinase Overexpression
Mahon, F.-X., Hayette, S., Lagarde, V., Belloc, F., Turcq, B., Nicolini, F., Belanger, C., Manley, P. W., Leroy, C., Etienne, G., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1008 · Cited by 212
Huisman, M. T., Chhatta, A. A., van Tellingen, O., Beijnen, J. H., & Schinkel, A. H. (2005) · International Journal of Cancer · doi:10.1002/ijc.21013 · Cited by 211
Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
K. Tiwari, A., Sodani, K., Dai, C.-L., R. Ashby, C., & Chen, Z.-S. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795164048 · Cited by 211
Self-citationTiwari, A. K., Sodani, K., Wang, S.-R., Kuang, Y.-H., Ashby, C. R., Chen, X., & Chen, Z.-S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.002 · Cited by 209
Self-citationLimtrakul, P., Chearwae, W., Shukla, S., Phisalphong, C., & Ambudkar, S. V. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9302-8 · Cited by 208
Kim, J., Zhang, X., Rieger-Christ, K. M., Summerhayes, I. C., Wazer, D. E., Paulson, K. E., & Yee, A. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513378200 · Cited by 203
Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs & monkeys.
Shankar, T. N., Shantha, N. V., Ramesh, H. P., Murthy, I. A. S., & Murthy, V. S. (1980) · PubMed · Cited by 201
Marchetti, S., de Vries, N. A., Buckle, T., Bolijn, M. J., van Eijndhoven, M. A. J., Beijnen, J. H., Mazzanti, R., van Tellingen, O., & Schellens, J. H. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2250 · Cited by 201
Analysis of the Drug Resistance Profile of Multidrug Resistance Protein 7 (ABCC10)
Hopper-Borge, E., Chen, Z.-S., Shchaveleva, I., Belinsky, M. G., & Kruh, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3111 · Cited by 198
Self-citationMolecular Pathways: Regulation and Therapeutic Implications of Multidrug Resistance
Chen, K. G., & Sikic, B. I. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1590 · Cited by 197
Targeted Cancer Therapies in the Twenty-First Century: Lessons From Imatinib
Stegmeier, F., Warmuth, M., Sellers, W. R., & Dorsch, M. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.297 · Cited by 192
Lapatinib: A Novel Dual Tyrosine Kinase Inhibitor with Activity in Solid Tumors
Nelson, M. H., & Dolder, C. R. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g387 · Cited by 192
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.
Bartlett, N. L., Lum, B. L., Fisher, G. A., Brophy, N. A., Ehsan, M. N., Halsey, J., & Sikic, B. I. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.4.835 · Cited by 189
Structure and mechanism of ABC transporters
Locher, K. P. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.06.005 · Cited by 189
Henningsson, A., Marsh, S., Loos, W. J., Karlsson, M. O., Garsa, A., Mross, K., Mielke, S., Viganò, L., Locatelli, A., Verweij, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1152 · Cited by 188
Gros, P., Dhir, R., Croop, J., & Talbot, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7289 · Cited by 185
Rocchi, E., Khodjakov, A., Volk, E. L., Yang, C.-H., Litman, T., Bates, S. E., & Schneider, E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2590 · Cited by 184
Nobili, S., Landini, I., Mazzei, T., & Mini, E. (2012) · Medicinal Research Reviews · doi:10.1002/med.20239 · Cited by 182
Kitazaki, T., Oka, M., Nakamura, Y., Tsurutani, J., Doi, S., Yasunaga, M., Takemura, M., Yabuuchi, H., Soda, H., & Kohno, S. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.03.035 · Cited by 182
Effects of dietary chemopreventive phytochemicals on P-glycoprotein function
Nabekura, T., Kamiyama, S., & Kitagawa, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.081 · Cited by 180
Dantzig, A. H., Shepard, R. L., Law, K. L., Tabas, L., Pratt, S., Gillespie, J. S., Binkley, S. N., Kuhfeld, M. T., Starling, J. J., & Wrighton, S. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34974-2 · Cited by 179
The Mechanism of Action of Multidrug-Resistance-Linked P-Glycoprotein
Sauna, Z. E., Smith, M. M., Müller, M., Kerr, K. M., & Ambudkar, S. V. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012875105006 · Cited by 178
Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily
Hopper, E., Belinsky, M. G., Zeng, H., Tosolini, A., Testa, J. R., & Kruh, G. D. (2001) · Cancer Letters · doi:10.1016/s0304-3835(00)00646-7 · Cited by 178
van den Heuvel-Eibrink, M., Wiemer, E., Prins, A., Meijerink, J., Vossebeld, P., van der Holt, B., Pieters, R., & Sonneveld, P. (2002) · Leukemia · doi:10.1038/sj.leu.2402496 · Cited by 175
Ambudkar, S. V., Kim, I.-W., Xia, D., & Sauna, Z. E. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.051 · Cited by 172
Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation
Thomas, S. M., & Grandis, J. R. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.10.003 · Cited by 171
Sildenafil Reverses ABCB1- and ABCG2-Mediated Chemotherapeutic Drug Resistance
Shi, Z., Tiwari, A. K., Shukla, S., Robey, R. W., Singh, S., Kim, I.-W., Bates, S. E., Peng, X., Abraham, I., Ambudkar, S. V., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3820 · Cited by 170
Self-citationAssociation of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia
Sissung, T. M., Mross, K., Steinberg, S. M., Behringer, D., Figg, W. D., Sparreboom, A., & Mielke, S. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.06.017 · Cited by 170
Tang, S. C., Lagas, J. S., Lankheet, N. A. G., Poller, B., Hillebrand, M. J., Rosing, H., Beijnen, J. H., & Schinkel, A. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.26000 · Cited by 165
Hu, S., Chen, Z., Franke, R., Orwick, S., Zhao, M., Rudek, M. A., Sparreboom, A., & Baker, S. D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0048 · Cited by 162
Self-citationMultidrug Resistance and Cancer: The Role of the Human ABC Transporter ABCG2
Ejendal, K. F., & Hrycyna, C. A. (2002) · Current Protein & Peptide Science · doi:10.2174/1389203023380521 · Cited by 161
Overcoming Multidrug Resistance in Cancer: Clinical Studies of P-Glycoprotein Inhibitors
Coley, H. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_15 · Cited by 160
Characterization of the Transport Properties of Human Multidrug Resistance Protein 7 (MRP7, ABCC10)
Chen, Z.-S., Hopper-Borge, E., Belinsky, M. G., Shchaveleva, I., Kotova, E., & Kruh, G. D. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.351 · Cited by 159
Self-citationDalton, W. S., Crowley, J. J., Salmon, S., Grogan, T. M., Laufman, L. R., Weiss, G. R., & Bonnet, J. D. (1995) · Cancer · Cited by 158
Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate
Jordanides, N. E., Jorgensen, H. G., Holyoake, T. L., & Mountford, J. C. (2006) · Blood · doi:10.1182/blood-2006-02-003145 · Cited by 158
Gréen, H., Söderkvist, P., Rosenberg, P., Horváth, G., & Peterson, C. O. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0950 · Cited by 157
Crizotinib, a small-molecule dual inhibitor of the c-Met and ALK receptor tyrosine kinases.
Rodig, S. J., & Shapiro, G. I. (2010) · PubMed · Cited by 155
O’Hare, T., Deininger, M. W., Eide, C. A., Clackson, T., & Druker, B. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3314 · Cited by 150
Kruh, G. D., Guo, Y., Hopper-Borge, E. A., Belinsky, M. G., & Chen, Z. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0114-1 · Cited by 142
Self-citationHopper-Borge, E. A., Xu, X. Q., Shen, T., Shi, Z., Chen, Z., & Kruh, G. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1420 · Cited by 140
Self-citationMultikinase inhibitors: a new option for the treatment of thyroid cancer
Gild, M. L., Bullock, M., Robinson, B. G., & Clifton-Bligh, R. J. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.141 · Cited by 140
Taxol metabolism and disposition in cancer patients.
Walle, T., Walle, U. K., Kumar, G. N., et al. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06589-4 · Cited by 137
Devine, S. E., Ling, V. W. T., & Melera, P. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4564 · Cited by 135
Lum, B. L., & Gosland, M. P. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30097-2 · Cited by 134
Chearwae, W., Shukla, S., Limtrakul, P., & Ambudkar, S. V. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0087 · Cited by 130
Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals
Nabekura, T., Yamaki, T., Ueno, K., & Kitagawa, S. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0676-4 · Cited by 128
Tiwari, A. K., Sodani, K. S., Dai, C.-L., Abuznait, A. H., Singh, S., Xiao, Z., Patel, A. S., Talele, T. T., Fu, L., Kaddoumi, A., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.001 · Cited by 128
Self-citationCesne, A. L., Blay, J., Bui, B., Bouché, O., Adenis, A., Dômont, J., Cioffi, A., Ray-Coquard, I. L., Lassau, N., Bonvalot, S., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.014 · Cited by 128
Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
Anreddy, N., Gupta, P., Kathawala, R. J., Patel, A. S., Wurpel, J. N. D., & Chen, Z. (2014) · Molecules · doi:10.3390/molecules190913848 · Cited by 126
Self-citationInhibition of P-glycoprotein function by tea catechins in KB-C2 cells
Kitagawa, S., Nabekura, T., & Kamiyama, S. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044003 · Cited by 126
Low levels of ABCG2 expression in adult AML blast samples
Abbott, B. L., Colapietro, A.-M., Barnes, Y., Marini, F. C., Andreeff, M., & Sorrentino, B. P. (2002) · Blood · doi:10.1182/blood-2002-01-0271 · Cited by 121
Gan, H. K., Šeruga, B., & Knox, J. J. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902980171 · Cited by 121
Dai, C.-L., Liang, Y.-J., Wang, Y.-S., Tiwari, A. K., Yan, Y., Wang, F., Chen, Z., Tong, X.-Z., & Fu, L. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.027 · Cited by 120
Self-citationMultidrug Resistance: Can New Drugs Help Chemotherapy Score Against Cancer?
Goldman, B. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.4.255 · Cited by 118
Morrow, C. S., Peklak-Scott, C., Bishwokarma, B., Kute, T. E., Smitherman, P. K., & Townsend, A. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.017988 · Cited by 105
Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance.
Smith, C. D., Zilfou, J. T., Stratmann, K., et al. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08534-7 · Cited by 105
Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance
Goler-Baron, V., & Assaraf, Y. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016007 · Cited by 104
Zhou, W., Zhang, X., Cheng, C., Wang, F., Wang, X., Liang, Y.-J., To, K. K. W., Wang, Z., Huang, H., & Fu, L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01849.x · Cited by 103
Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals
Nabekura, T., Yamaki, T., Hiroi, T., Ueno, K., & Kitagawa, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.010 · Cited by 101
Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance
Kuang, Y., Shen, T., Chen, X. '., Sodani, K. S., Hopper-Borge, E. A., Tiwari, A. K., Lee, J. W. K. K., Fu, L., & Chen, Z. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.021 · Cited by 100
Self-citationYin, J. A. L., Wheatley, K., Rees, J. K. H., Burnett, A. K., & Party, T. U. M. A. L. W. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02785.x · Cited by 100
Kim, J. E., Singh, R. R., Cho‐Vega, J. H., Drakos, E., Davuluri, Y., Khokhar, F. A., Fayad, L., Medeiros, L. J., & Vega, F. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.98 · Cited by 99
Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia
Sauerbrey, A., Sell, W., Steinbach, D., Voigt, A., & Zintl, F. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03550.x · Cited by 97
Tabe, Y., Konopleva, M. Y., Contractor, R., Munsell, M. F., Schober, W. D., Jin, L., Tsutsumi‐Ishii, Y., Nagaoka, I., Igari, J., & Andreeff, M. (2005) · Blood · doi:10.1182/blood-2004-10-4126 · Cited by 96
The specificity of JAK3 kinase inhibitors
Changelian, P. S., Moshinsky, D. J., Kuhn, C. F., Flanagan, M. E., Munchhof, M. J., Harris, T. M., Whipple, D. A., Doty, J. L., Sun, J., Kent, C. R., et al. (2007) · Blood · doi:10.1182/blood-2007-09-115030 · Cited by 96
Gene rearrangement: a novel mechanism for MDR-1 gene activation.
Mickley, L. A., Spengler, B. A., Knutsen, T. A., Biedler, J. L., & Fojo, T. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119362 · Cited by 96
Zheng, L.-S., Wang, F., Li, Y., Zhang, X., Chen, L., Liang, Y.-J., Dai, C.-L., Yan, Y., Tao, L.-Y., Mi, Y., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005172 · Cited by 95
Bates, S. E., Medina-Pérez, W. Y., Kohlhagen, G., Antony, S., Nadjem, T., Robey, R. W., & Pommier, Y. G. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063149 · Cited by 95
Tsuruo, T., Hamada, H., Sato, S., & Heike, Y. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb01688.x · Cited by 93
Sen, R., Natarajan, K., Bhullar, J., Shukla, S., Fang, H.-B., Cai, L., Chen, Z., Ambudkar, S. V., & Baer, M. R. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0302 · Cited by 93
Self-citationParekh, H. K., Wiesen, K. M., & Simpkins, H. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)83383-7 · Cited by 90
Vemurafenib and BRAF Inhibition: A New Class of Treatment for Metastatic Melanoma
Luke, J. J., & Hodi, F. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2197 · Cited by 89
Kim, Y. H., Ishii, G., Goto, K., Ota, S., Kubota, K., Murata, Y., Mishima, M., Saijo, N., Nishiwaki, Y., & Ochiai, A. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.10.008 · Cited by 87
Contribution of Abcc10 (Mrp7) to In Vivo Paclitaxel Resistance as Assessed in Abcc10−/− Mice
Hopper-Borge, E. A., Churchill, T., Paulose, C., Nicolas, É., Jacobs, J. D., Ngo, O., Kuang, Y., Grinberg, A., Westphal, H., Chen, Z., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3623 · Cited by 86
Self-citationOvercoming Multidrug Resistance in Human Cancer Cells by Natural Compounds
Nabekura, T. (2010) · Toxins · doi:10.3390/toxins2061207 · Cited by 86
Correction: Reversal of Multidrug Resistance by Lapatinib
(2008) · Cancer Research · doi:10.1158/0008-5472.can-68-24-cor · Cited by 86
Ding, P.-R., Tiwari, A. K., Ohnuma, S., Lee, J. W. K. K., An, X., Dai, C.-L., Lu, Q.-S., Singh, S., Yang, D., Talele, T. T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019329 · Cited by 83
Self-citationABC transporters, mechanisms and biology: an overview
Holland, I. B. (2011) · Essays in Biochemistry · doi:10.1042/bse0500001 · Cited by 83
Dominant effector genetics in mammalian cells
Xu, X. M., Leo, C., Jang, Y., Chan, E., Padilla, D., Huang, B. C. B., Lin, T., Gururaja, T. L., Hitoshi, Y., Lorens, J. B., et al. (2001) · Nature Genetics · doi:10.1038/83717 · Cited by 81
Advani, R. H., Fisher, G. A., Lum, B. L., Hausdorff, J., Halsey, J., Litchman, M., & Sikic, B. I. (2001) · PubMed · Cited by 81
Morschhauser, F., Zinzani, P. L., Burgess, M., Sloots, L., Bouafia, F., & Dumontet, C. (2007) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190701190169 · Cited by 81
Sonneveld, P., Schoester, M., & Leeuw, K. D. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.8.1584 · Cited by 80
Assaraf, Y. G., Rothem, L., Hooijberg, J. H., Stark, M., Ifergan, I., Kathmann, I., Dijkmans, B. A. C., Peters, G. J., & Jansen, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209186200 · Cited by 76
Oguri, T., Ozasa, H., Uemura, T., Bessho, Y., Miyazaki, M., Maeno, K., 前田, 浩., Sato, S., & Ueda, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2088 · Cited by 76
Fracasso, P. M., Goldstein, L. J., de Alwis, D. P., Rader, J. S., Arquette, M. A., Goodner, S. A., Wright, L. P., Fears, C. L., Gazak, R. J., Andre, V. A. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0452 · Cited by 76
Peng, X., Tiwari, A. K., Wu, H.-C., & Chen, Z. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10327 · Cited by 73
Self-citationShen, T., Kuang, Y., Ashby, C. R., Yu, L., Angel, C., Zhou, Y. Q., Chen, X., Tiwari, A. K., Hopper-Borge, E. A., Ouyang, J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007520 · Cited by 72
Self-citationEffects of sildenafil citrate (viagra) on blood pressure in normotensive and hypertensive men
Vardi, Y., Klein, L., Nassar, S., Sprecher, E., & Gruenwald, I. (2002) · Urology · doi:10.1016/s0090-4295(02)01510-8 · Cited by 71
Leschziner, G. D., Zabaneh, D., Pirmohamed, M., Owen, A., Rogers, J., Coffey, A. J., Balding, D. J., Bentley, D., & Johnson, M. R. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000197467.21964.67 · Cited by 71
Sumizawa, T., Chen, Z., Chuman, Y., Seto, K., Furukawa, T., Haraguchi, M., Tani, A., Shudo, N., & Akiyama, S.-I. (1997) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13480-3 · Cited by 71
Self-citationEjendal, K. F. K., Diop, N. K., Schweiger, L. C., & Hrycyna, C. A. (2006) · Protein Science · doi:10.1110/ps.051998406 · Cited by 69
Kanzaki, A., Takebayashi, Y., Ren, X. Q., Miyashita, H., Mori, S., Akiyama, S. I., & Pommier, Y. G. (2002) · PubMed · Cited by 69
Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance
Abraham, I., Sayed, K. A. E., Chen, Z., & Guo, H. (2012) · Marine Drugs · doi:10.3390/md10102312 · Cited by 68
Self-citationMinocha, M., Khurana, V., Qin, B. Y., Pal, D., & Mitra, A. K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.038 · Cited by 66
ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer
Oguri (1994) · Oncology Reports · doi:10.3892/or_00000217 · Cited by 65
Wang, Y., Zhang, Y., Kathawala, R. J., & Chen, Z. (2014) · Cancers · doi:10.3390/cancers6041925 · Cited by 63
Self-citationLocher, K. P., & Borths, E. L. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00289-3 · Cited by 62
Aoki, S., Chen, Z., Higasiyama, K., Setiawan, I., Akiyama, S., & Kobayashi, M. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01177.x · Cited by 61
Self-citationShi, Z., Jain, S. K., Kim, I., Peng, X., Abraham, I., Youssef, D. T. A., Fu, L., Sayed, K. A. E., Ambudkar, S. V., & Chen, Z. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00554.x · Cited by 59
Self-citationChen, Z., Aoki, S., Komatsu, M., Ueda, K., Sumizawa, T., Furukawa, T., Okumura, H., Ren, X., Belinsky, M. G., Lee, K., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1290 · Cited by 58
Self-citationMalofeeva, E. V., Domanitskaya, N., Gudima, M., & Hopper-Borge, E. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1340 · Cited by 58
Zhang, H., Patel, A. S., Ma, S., Li, X. J., Zhang, Y.-K., Yang, P., Kathawala, R. J., Wang, Y., Anreddy, N., Fu, L., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12889 · Cited by 56
Self-citationKathawala, R. J., Wang, Y., Ashby, C. R., & Chen, Z. (2013) · 癌症:英文版 · doi:10.5732/cjc.013.10122 · Cited by 56
Self-citationNabekura, T., Yamaki, T., & Kitagawa, S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.025 · Cited by 56
Wang, Y., Kathawala, R. J., Zhang, Y., Patel, A. S., Kumar, P., Shukla, S., Fung, K. L., Ambudkar, S. V., Talele, T. T., & Chen, Z. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.006 · Cited by 56
Self-citationDeng, W., Dai, C.-L., CHEN, J.-J., Kathawala, R. J., SUN, Y.-L., CHEN, H.-F., Fu, L., & Chen, Z. (2013) · Oncology Reports · doi:10.3892/or.2013.2362 · Cited by 54
Self-citationABCB1 G1199A Polymorphism and Ovarian Cancer Response to Paclitaxel
Gréen, H., Söderkvist, P., Rosenberg, P., Horváth, G., & Peterson, C. O. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21169 · Cited by 53
Hu, S., Niu, H., Inaba, H., Orwick, S. J., Rose, C., Panetta, J. C., Yang, S., Pounds, S. B., Fan, Y., Calabrese, C. R., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr107 · Cited by 53
Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein
Shi, Z., Liang, Y.-J., Chen, Z., Wang, X., Ding, Y., Chen, L., & Fu, L. (2007) · Oncology Reports · doi:10.3892/or.17.4.969 · Cited by 50
Self-citationMultitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions
Ellis, P. M., & Alsaleh, K. A. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.02.004 · Cited by 49
The role of breast cancer resistance protein in acute lymphoblastic leukemia.
Plasschaert, S. L. A., van der Kolk, D. M., de Bont, E. S. J. M., Kamps, W. A., Morisaki, K., Bates, S. E., Scheffer, G. L., Scheper, R. J., Vellenga, E., & de Vries, E. G. E. (2003) · PubMed · Cited by 49
Sodani, K. S., Patel, A. S., Anreddy, N., Singh, S., Yang, D., Kathawala, R. J., Kumar, P., Talele, T. T., & Chen, Z. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.02.012 · Cited by 47
Self-citationReversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar
Sun, Y.-L., Chen, J.-J., Kumar, P., Chen, K., Sodani, K. S., Patel, A. S., Chen, Y., Chen, S.-D., Jiang, W.-Q., & Chen, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055576 · Cited by 47
Self-citationKelly, R. J., Robey, R. W., Chen, C. C., Draper, D., Luchenko, V. L., Barnett, D., Oldham, R. K., Caluag, Z., Frye, A. R., Steinberg, S. M., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0080 · Cited by 45
Chen, J., Sun, Y., Tiwari, A. K., Xiao, Z., Sodani, K. S., Yang, D., Vispute, S. G., Jiang, W., Chen, S., & Chen, Z. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02328.x · Cited by 44
Self-citationGemcitabine Cytotoxicity: Interaction of Efflux and Deamination
Rudin, D., Li, L., Niu, N., Kalari, K. R., & Gilbert, J. A. (2011) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.1000107 · Cited by 44
Wang, D., Patel, A. S., Shukla, S., Zhang, Y.-K., Wang, Y.-J., Kathawala, R. J., Robey, R. W., Zhang, L., Yang, D., Talele, T. T., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2102 · Cited by 43
Self-citationAssaraf, Y. G., Molina, A., & SCHIMKE, R. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51467-8 · Cited by 43
Naramoto, H., Uematsu, T., Uchihashi, T., Doto, R., Matsuura, T., Usui, Y., Uematsu, S., Li, X., Takahashi, M., Yamaoka, M., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.2.393 · Cited by 41
Kathawala, R. J., Sodani, K. S., Chen, K., Patel, A. S., Abuznait, A. H., Anreddy, N., Sun, Y.-L., Kaddoumi, A., Ashby, C. R., & Chen, Z. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0743 · Cited by 40
Self-citationZhang, H., Wang, Y.-J., Zhang, Y.-K., Wang, D.-S., Kathawala, R. J., Patel, A., Talele, T. T., Chen, Z.-S., & Fu, L.-W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.04.008 · Cited by 34
Self-citationZhang, H., Kathawala, R. J., Wang, Y.-J., Zhang, Y.-K., Patel, A. S., Shukla, S., Robey, R. W., Talele, T. T., Ashby, C. R., Ambudkar, S. V., et al. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.03.026 · Cited by 34
Self-citation
Cited by
Chen, Z., Shi, T., Zhang, L., Zhu, P., Deng, M., Huang, C., Hu, T., Jiang, L., & Li, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.010 · Cited by 729
Self-citationLi, W., Zhang, H., Assaraf, Y. G., Zhao, K., Xu, X., Xie, J., Yang, D.-H., & Chen, Z.-S. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.05.001 · Cited by 673
Self-citationThe multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
Catalano, A., Iacopetta, D., Ceramella, J., Scumaci, D., Giuzio, F., Saturnino, C., Aquaro, S., Rosano, C., & Sinicropi, M. S. (2022) · Molecules · doi:10.3390/molecules27030616 · Cited by 450
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Mosca, L., Ilari, A., Fazi, F., Assaraf, Y. G., & Colotti, G. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100742 · Cited by 385
Metadata
- Authors
- Kathawala, R. J., Gupta, P., Ashby, C. R., & Chen, Z.-S.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 18
- Pages
- 1-17
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W1981140460
- Cited by
- 777
- References
- 216
- FWCI
- 24.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.